October 9, 2015
NATIONAL HARBOR, Md. — Patients with HIV are at increased risk for HF compared with noninfected patients, but optimal treatment for HF is significantly less common among those with HIV, researchers reported at the Heart Failure Society of America Annual Scientific Meeting.
“Despite improvements in HIV treatment, [these] patients are still at high risk for CVD,” Sadeer G. Al-Kindi, MD, University Hospitals Case Medical Center in Cleveland, said during a presentation. “We sought to estimate the prevalence of HF in HIV patients because this has not been explored before.”